ArticleOncoTargets and therapy2009

Update on the rational use of Y-ibritumomab tiuxetan in the treatment of follicular lymphoma.

Martina Lehnert et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.